Loading clinical trials...
Loading clinical trials...
Patients with POTS may not adequately expand their plasma volume in response to a high-sodium (Na+) diet. Mechanisms involved in the regulation of plasma volume, such as the renin-angiotensin-aldoster...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Vanderbilt University
Collaborators
NCT05212129 · Functional Gastrointestinal Disorders, Hypermobile Ehlers-Danlos Syndrome, and more
NCT06593600 · Postural Orthostatic Tachycardia Syndrome (POTS)
NCT04806620 · Post-Acute COVID-19 Syndrome, ME/CFS, and more
NCT07196397 · Vasovagal Syndrome VVS, Cardioinhibitory Carotid Sinus Syndrome CSS, and more
NCT06616363 · POTS - Postural Orthostatic Tachycardia Syndrome
Vanderbilt University Medical Center
Nashville, Tennessee
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions